Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. The company is headquartered in Calgary, Alberta. The company went IPO on 2024-11-27. The firm holds an exclusive worldwide license to patented technology that targets solid tumors. The firm is engaged in developing and commercializing treatments for various types of cancer. Its solution focuses on targeting cancer cells, effectively eliminating them and preventing their regrowth. Its licensed technology focuses on Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors. Its SynoGraph platform merges genomic, proteomic, and multimodal datasets to uncover deep insights into disease mechanisms, potentially enabling more personalized and effective treatment strategies.
Follow-Up Questions
Onco-Innovations Ltd 的 CEO 是谁？
Mr. Thomas Oshaughnessy 是 Onco-Innovations Ltd 的 Chief Executive Officer，自 2024 加入公司。
ONNVF 股票的价格表现如何？
ONNVF 的当前价格为 $0，在上个交易日 decreased 了 0%。
Onco-Innovations Ltd 的主要业务主题或行业是什么？
Onco-Innovations Ltd 属于 Biotechnology 行业，该板块是 Health Care
